Potassium Acetate Injection, Solution, Concentrate
Product Images NDC 0409-3294

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Acetate (NDC 0409-3294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Principal Display Panel (50 mL Vial Label)
Label for Potassium Acetate Injection, USP, 100 mEq/50 mL (2 mEq/mL) intravenous solution concentrate. The 50 mL vial is distributed by Hospira, Inc. It states the product is a pharmacy bulk package requiring dilution before intravenous use. The label includes handling instructions, NDC 0409-3294-61, and storage conditions.*
FDA Label Image

Principal Display Panel (50 mL Vial Tray)

Principal Display Panel (50 mL Vial Tray)
Label for Potassium Acetate Injection, USP 100 mEq/50 mL (2 mEq/mL) in a 50 mL vial. The label states it is a pharmacy bulk package not for direct infusion, requiring dilution before intravenous use. It is distributed by Hospira, Inc. The label includes storage instructions and cautions regarding use and handling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.